These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8697733)

  • 21. Quis Custodiet Ipsos Custodes (Who Controls the Controllers)? Two Decades of Studies on HDAC9.
    Brancolini C; Di Giorgio E; Formisano L; Gagliano T
    Life (Basel); 2021 Jan; 11(2):. PubMed ID: 33513699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDA insists on more women in drug trials.
    Josefson D
    BMJ; 1997 Oct; 315(7112):833. PubMed ID: 9353497
    [No Abstract]   [Full Text] [Related]  

  • 23. Quis Custodiet Custodes?
    J Psychol Med Ment Pathol (Lond); 1876 Apr; 2(Pt 1):116-124. PubMed ID: 28906837
    [No Abstract]   [Full Text] [Related]  

  • 24. New Food and Drug Administration-based oversight over genetic testing.
    Press RD
    Mol Diagn; 2001 Dec; 6(4):348-9. PubMed ID: 11837221
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA relaxes proof rules for food health claims.
    Health News; 2003 Mar; 9(3):6-7. PubMed ID: 12703437
    [No Abstract]   [Full Text] [Related]  

  • 26. If PBMs Guard Access to Drugs, Then Quis Custodiet Ipsos Custodies? (Who Will Guard the Guardians?).
    Carter AW; Heinemann L
    J Diabetes Sci Technol; 2016 Nov; 10(6):1406-1410. PubMed ID: 27381029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quis custodeit custodes ipsos?
    Spodick DH
    Circulation; 1994 Nov; 90(5):2565-6. PubMed ID: 7832873
    [No Abstract]   [Full Text] [Related]  

  • 28. Food and drug administration expanded access to treatment: implications for oncology patients.
    Freedman RS; Markman M
    Cancer; 2007 Jun; 109(11):2157-60. PubMed ID: 17450587
    [No Abstract]   [Full Text] [Related]  

  • 29. US watchdog finds bias against morning-after pill.
    Wadman M
    Nature; 2005 Nov; 438(7067):401. PubMed ID: 16306946
    [No Abstract]   [Full Text] [Related]  

  • 30. One year after launch, drug safety board is dubbed a failure.
    Wadman M
    Nat Med; 2006 Mar; 12(3):258. PubMed ID: 16520751
    [No Abstract]   [Full Text] [Related]  

  • 31. Induction of labor in the nulliparous gravida with an unfavorable cervix.
    Mercer BM
    Obstet Gynecol; 2005 Apr; 105(4):688-9. PubMed ID: 15802391
    [No Abstract]   [Full Text] [Related]  

  • 32. Challenges in human subject protection.
    Nightingale SL
    Food Drug Law J; 1995; 50(4):493-501. PubMed ID: 10343016
    [No Abstract]   [Full Text] [Related]  

  • 33. Requiem for flavonoid drugs.
    Med Lett Drugs Ther; 1968 Feb; 10(3):9-10. PubMed ID: 5694258
    [No Abstract]   [Full Text] [Related]  

  • 34. Anticipating REMS.
    Nat Rev Drug Discov; 2008 Dec; 7(12):963. PubMed ID: 19043440
    [No Abstract]   [Full Text] [Related]  

  • 35. Hard times at the FDA.
    Nat Immunol; 2005 Feb; 6(2):115. PubMed ID: 15662433
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug safety on trial.
    Nature; 2005 Mar; 434(7033):545. PubMed ID: 15800579
    [No Abstract]   [Full Text] [Related]  

  • 37. First noninvasive cholesterol test cleared by FDA.
    Expert Rev Mol Diagn; 2002 Jul; 2(4):296. PubMed ID: 12138489
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantitative decision analysis: a work in progress.
    Temple R
    Clin Pharmacol Ther; 2007 Aug; 82(2):127-30. PubMed ID: 17632535
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of the cervicoscope in general practice.
    Colvin D
    Br J Gen Pract; 1997 Jan; 47(414):43-4. PubMed ID: 9115794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A pipette for taking samples of secretion from the surface of the cervix uteri].
    Vaĭner LL
    Lab Delo; 1966; 8():505-6. PubMed ID: 4176254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.